Redeye: Sensys Gatso - Temporary Weakness to Turn to Strength in Late 2023
Redeye thinks that Sensys Gatso currently displays extraordinarily low sales and an extraordinarily high-cost base. From late 2023, Redeye thinks the cost base will normalize and that revenues will rather be somewhat heightened. This indicates strong revenue growth combined with a hefty margin expansion that will likely attract many investors. Redeye lowers its valuation range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/